Pharma’s support of Trump’s drug pricing plan is fraying

Last quarter, Pfizer Chief Ian Read was upbeat on the Trump administration’s plan to lower drug prices, even after a Trump tweet that led to his company deferring planned price increases.

Source link

Leave a Comment

At least 20 dead in blasts at sports center in Afghan capitalClampdown on violence against NHS staff